USP seeks early Input on new NMR Method
Recommendation

9-11 December 2025
How to implement cGMP requirements in the everyday practice of quality control laboratories
USP has announced a General Chapter Prospectus for a proposed new chapter <319> Nuclear Magnetic Resonance Spectroscopy Block Length Determination for Lactide-Glycolide Polymers. The notice was posted on 31 October 2025, and USP is seeking early input from stakeholders until 30 November 2025, ahead of an anticipated proposal in PF 52(2) (March–April 2026).
Lactide-glycolide (PLG) and lactic acid-glycolic acid (PLGA) polymers are widely used as excipients in extended-release drug products and certain medical devices. However, due to their complex structure and variability, standardized analytical methods remain limited. This has often created challenges for manufacturers, particularly in the development and regulatory approval of generic products containing PLG/PLGA.
USP has previously introduced stand-alone chapters <315> and <316> to support improved characterization (NMR for number-average molecular weight and SEC for molecular weight distribution). The proposed new chapter <319> would extend this approach by providing a standardized NMR procedure to determine block length, a parameter considered critical to polymer performance.
Related GMP News
26.11.2025FDA Warning Letter Highlights Deficiencies in SST and HPLC Practices
13.11.2025Proposed Revision of USP <1225> Published in the Pharmacopeial Forum
13.11.2025Recent Publications Highlighting Topics to be Discussed at PharmaLab 2025
12.11.2025FDA Warning Letter: Several Analytical Deficiencies Identified at Chinese Manufacturer


